A Study to Evaluate Safety and Tolerability of Multiple Doses of MEDI-546 in Adult Subjects With Scleroderma

NCT00930683 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Scleroderma

Interventions

DRUG: MEDI-546
DRUG: MEDI-546
DRUG: MEDI-546
DRUG: MEDI-546
DRUG: MEDI-546
DRUG: MEDI-546
DRUG: MEDI-546
DRUG: MEDI-546
DRUG: MEDI-546

Sponsor

MedImmune LLC